377 related articles for article (PubMed ID: 30619337)
1. High Levels of Eomes Promote Exhaustion of Anti-tumor CD8
Li J; He Y; Hao J; Ni L; Dong C
Front Immunol; 2018; 9():2981. PubMed ID: 30619337
[TBL] [Abstract][Full Text] [Related]
2. Co-inhibitory Molecule B7 Superfamily Member 1 Expressed by Tumor-Infiltrating Myeloid Cells Induces Dysfunction of Anti-tumor CD8
Li J; Lee Y; Li Y; Jiang Y; Lu H; Zang W; Zhao X; Liu L; Chen Y; Tan H; Yang Z; Zhang MQ; Mak TW; Ni L; Dong C
Immunity; 2018 Apr; 48(4):773-786.e5. PubMed ID: 29625896
[TBL] [Abstract][Full Text] [Related]
3. T-Bet and Eomes Regulate the Balance between the Effector/Central Memory T Cells versus Memory Stem Like T Cells.
Li G; Yang Q; Zhu Y; Wang HR; Chen X; Zhang X; Lu B
PLoS One; 2013; 8(6):e67401. PubMed ID: 23826287
[TBL] [Abstract][Full Text] [Related]
4. Characterization of eomesodermin and T-bet expression by allostimulated CD8
Perez-Gutierrez A; Metes DM; Lu L; Hariharan S; Thomson AW; Ezzelarab MB
Clin Exp Immunol; 2018 Nov; 194(2):259-272. PubMed ID: 30246373
[TBL] [Abstract][Full Text] [Related]
5. T-bet and eomesodermin are required for T cell-mediated antitumor immune responses.
Zhu Y; Ju S; Chen E; Dai S; Li C; Morel P; Liu L; Zhang X; Lu B
J Immunol; 2010 Sep; 185(6):3174-83. PubMed ID: 20713880
[TBL] [Abstract][Full Text] [Related]
6. Eomes cannot replace its paralog T-bet during expansion and differentiation of CD8 effector T cells.
Fixemer J; Hummel JF; Arnold F; Klose CSN; Hofherr A; Weissert K; Kögl T; Köttgen M; Arnold SJ; Aichele P; Tanriver Y
PLoS Pathog; 2020 Sep; 16(9):e1008870. PubMed ID: 32991634
[TBL] [Abstract][Full Text] [Related]
7. IRF4 Regulates the Ratio of T-Bet to Eomesodermin in CD8+ T Cells Responding to Persistent LCMV Infection.
Nayar R; Schutten E; Jangalwe S; Durost PA; Kenney LL; Conley JM; Daniels K; Brehm MA; Welsh RM; Berg LJ
PLoS One; 2015; 10(12):e0144826. PubMed ID: 26714260
[TBL] [Abstract][Full Text] [Related]
8. T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection.
Buggert M; Tauriainen J; Yamamoto T; Frederiksen J; Ivarsson MA; Michaëlsson J; Lund O; Hejdeman B; Jansson M; Sönnerborg A; Koup RA; Betts MR; Karlsson AC
PLoS Pathog; 2014 Jul; 10(7):e1004251. PubMed ID: 25032686
[TBL] [Abstract][Full Text] [Related]
9. Targeting Nuclear LSD1 to Reprogram Cancer Cells and Reinvigorate Exhausted T Cells via a Novel LSD1-EOMES Switch.
Tu WJ; McCuaig RD; Tan AHY; Hardy K; Seddiki N; Ali S; Dahlstrom JE; Bean EG; Dunn J; Forwood J; Tsimbalyuk S; Smith K; Yip D; Malik L; Prasanna T; Milburn P; Rao S
Front Immunol; 2020; 11():1228. PubMed ID: 32612611
[TBL] [Abstract][Full Text] [Related]
10. Checkpoint blockade immunotherapy relies on T-bet but not Eomes to induce effector function in tumor-infiltrating CD8+ T cells.
Berrien-Elliott MM; Yuan J; Swier LE; Jackson SR; Chen CL; Donlin MJ; Teague RM
Cancer Immunol Res; 2015 Feb; 3(2):116-24. PubMed ID: 25516478
[TBL] [Abstract][Full Text] [Related]
11. Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signaling.
Grange M; Verdeil G; Arnoux F; Griffon A; Spicuglia S; Maurizio J; Buferne M; Schmitt-Verhulst AM; Auphan-Anezin N
J Immunol; 2013 Oct; 191(7):3712-24. PubMed ID: 24006458
[TBL] [Abstract][Full Text] [Related]
12. Ectopic expression of a T-box transcription factor, eomesodermin, renders CD4(+) Th cells cytotoxic by activating both perforin- and FasL-pathways.
Eshima K; Chiba S; Suzuki H; Kokubo K; Kobayashi H; Iizuka M; Iwabuchi K; Shinohara N
Immunol Lett; 2012 May; 144(1-2):7-15. PubMed ID: 22425747
[TBL] [Abstract][Full Text] [Related]
13. Effect of Cytomegalovirus (CMV) and Ageing on T-Bet and Eomes Expression on T-Cell Subsets.
Hassouneh F; Lopez-Sejas N; Campos C; Sanchez-Correa B; Tarazona R; Pera A; Solana R
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28661443
[TBL] [Abstract][Full Text] [Related]
14. Differential localization of T-bet and Eomes in CD8 T cell memory populations.
McLane LM; Banerjee PP; Cosma GL; Makedonas G; Wherry EJ; Orange JS; Betts MR
J Immunol; 2013 Apr; 190(7):3207-15. PubMed ID: 23455505
[TBL] [Abstract][Full Text] [Related]
15. Infection history determines the differentiation state of human CD8+ T cells.
van Aalderen MC; Remmerswaal EB; Verstegen NJ; Hombrink P; ten Brinke A; Pircher H; Kootstra NA; ten Berge IJ; van Lier RA
J Virol; 2015 May; 89(9):5110-23. PubMed ID: 25717102
[TBL] [Abstract][Full Text] [Related]
16. Cutting edge: The transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche.
Banerjee A; Gordon SM; Intlekofer AM; Paley MA; Mooney EC; Lindsten T; Wherry EJ; Reiner SL
J Immunol; 2010 Nov; 185(9):4988-92. PubMed ID: 20935204
[TBL] [Abstract][Full Text] [Related]
17. Eomesodermin driven IL-10 production in effector CD8
Reiser J; Sadashivaiah K; Furusawa A; Banerjee A; Singh N
Cell Immunol; 2019 Jan; 335():93-102. PubMed ID: 30528350
[TBL] [Abstract][Full Text] [Related]
18. Endogenous antigen presentation impacts on T-box transcription factor expression and functional maturation of CD8+ T cells.
Smith C; Elhassen D; Gras S; Wynn KK; Dasari V; Tellam J; Tey SK; Rehan S; Liu YC; Rossjohn J; Burrows SR; Khanna R
Blood; 2012 Oct; 120(16):3237-45. PubMed ID: 22942184
[TBL] [Abstract][Full Text] [Related]
19. Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation.
Takemoto N; Intlekofer AM; Northrup JT; Wherry EJ; Reiner SL
J Immunol; 2006 Dec; 177(11):7515-9. PubMed ID: 17114419
[TBL] [Abstract][Full Text] [Related]
20. ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression.
Cao Y; Trillo-Tinoco J; Sierra RA; Anadon C; Dai W; Mohamed E; Cen L; Costich TL; Magliocco A; Marchion D; Klar R; Michel S; Jaschinski F; Reich RR; Mehrotra S; Cubillos-Ruiz JR; Munn DH; Conejo-Garcia JR; Rodriguez PC
Nat Commun; 2019 Mar; 10(1):1280. PubMed ID: 30894532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
